METROPOLITAN LIFE INSURANCE CO/NY - Y-MABS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 115 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,200
-19.7%
2,0550.0%0.00%0.0%
Q2 2023$13,953
+35.5%
2,0550.0%0.00%0.0%
Q1 2023$10,296
-8.0%
2,055
-10.4%
0.00%0.0%
Q4 2022$11,190
-66.3%
2,293
-0.5%
0.00%
-50.0%
Q3 2022$33,238
-4.7%
2,3050.0%0.00%0.0%
Q2 2022$34,875
+27.4%
2,3050.0%0.00%
+100.0%
Q1 2022$27,383
-82.4%
2,305
-75.9%
0.00%
-50.0%
Q4 2021$155,178
-43.2%
9,5730.0%0.00%
-50.0%
Q3 2021$273,213
-14.3%
9,573
+1.5%
0.00%0.0%
Q2 2021$318,835
+17.7%
9,433
+5.3%
0.00%0.0%
Q1 2021$270,981
-40.9%
8,961
-3.3%
0.00%
-42.9%
Q4 2020$458,661
+29.0%
9,2640.0%0.01%
+16.7%
Q3 2020$355,645
-11.1%
9,2640.0%0.01%
-14.3%
Q2 2020$400,205
+110.5%
9,264
+27.1%
0.01%
+75.0%
Q1 2020$190,165
-16.5%
7,2860.0%0.00%0.0%
Q4 2019$227,688
+19.9%
7,2860.0%0.00%
+33.3%
Q3 2019$189,873
+422.5%
7,286
+358.5%
0.00%
+200.0%
Q2 2019$36,340–1,589–0.00%–
 Download
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders